Category: Funding RoundupSyndicate content

ForSight Vision5 lands $15M Series C round

April 18, 2014 by Brad Perriello

ForSight Vision5 says it landed a $15 million Series C round for its Helios ocular insert.

ForSight Vision5 lands $15M Series C round

ForSight Vision5, which is developing devices to treat front-of-the-eye conditions such as glaucoma and dry eye disease, said it pulled down a $15 million Series C round.

ForSight Vision5 is a spinout of ForSight Labs, a Menlo Park, Calif.-based incubator focused on developing ophthalmic treatments.

Cardica hopes to raise $44M in public offering

April 17, 2014 by Arezu Sarvestani

California surgical devices maker Cardica details a public offering of common and preferred stock aimed at raising $43.9 million to support U.S. sales and marketing efforts.

Cardica hopes to raise $44M in public offering

Cardica unveiled the details of an upcoming public offering of stock, aimed at raising $43.9 million to support commercial efforts for the company's MicroCutter XCHANGE 30 minimally invasive stapling system.

Cardiac Dimensions closes $20M equity round

April 17, 2014 by Brad Perriello

Cardiac Dimensions raises $20 million from a syndicate of international investors for its Carillon mitral valve implant.

Cardiac Dimensions closes $20M equity round

Cardiac Dimensions said it raised $20 million from a syndicate of international investors for its Carillon mitral valve implant.

M.H. Carnegie & Co. and Lumira Capital led the round for Kirkland, Wash.-based Cardiac Dimensions, according to a press release. Investors in Australia, the U.S. and Canada also participated, the company said.

Diabetes: Omada Health raises $23M for digital prevention programs

April 15, 2014 by Arezu Sarvestani

Silicon Valley digital health company Omada Health raises $23 million in support of its online chronic disease prevention programs, focused initially on diabetes.

Diabetes: Omada Health closes $23M Series B for online prevention programs

San Francisco-based Omada Health is looking to boost its workforce and widen its focus with a newly closed $23 million Series B round.

Funding was led by Andreessen Horowitz, which also contributed general partner Balaji Srinivasan to Omada's board of directors. Other funding included Kaiser Permanente Ventures and existing investors U.S. Venture Partners and The Vertical Group, Omada announced.

Tendyne Holdings secures $25M for transcatheter mitral valves

April 10, 2014 by Arezu Sarvestani

Minnesota-based Tendyne Holdings raises $25 million in a Series C funding round supporting its transcatheter mitral valve implantation systems for treating mitral regurgitation.

Tendyne Holdings secures $25M for transcatheter mitral valves

Medtech startup Tendyne Holdings landed $25 million in Series C funding, planning on using the new cash for further research & development of its transcatheter mitral valve technology.

The 4-year-old company's device provides minimally invasive treatment of mitral regurgitation. Tendyne is working on engineering an implantation system that would allow physicians to re-position or retrieve the valve even after full deployment.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp